Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Journey Medical Corporation (DERM) had Debt to Capital Ratio of 0.53 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$15.01M |
|
$-3.80M |
|
$4.94M |
|
$10.07M |
|
$17.89M |
|
$-2.88M |
|
$-0.86M |
|
$-3.74M |
|
$-3.74M |
|
$-3.80M |
|
$-3.80M |
|
$-3.80M |
|
$-3.80M |
|
$-2.88M |
|
$-1.67M |
|
23.29M |
|
23.29M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$51.27M |
|
-- |
|
$29.89M |
|
$81.16M |
|
$40.48M |
|
$21.36M |
|
$21.43M |
|
$61.91M |
|
$19.25M |
|
$-10.49M |
|
$19.25M |
|
23.47M |
|
| Cash Flow Statement Financials | |
$-3.77M |
|
-- |
|
$3.76M |
|
$20.30M |
|
$20.29M |
|
$-0.01M |
|
$2.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.27 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.53 |
1.30 |
|
67.09% |
|
-19.16% |
|
-19.16% |
|
-- |
|
-24.89% |
|
-25.29% |
|
$-3.77M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.38 |
|
0.96 |
|
93.81 |
|
-19.72% |
|
36.19% |
|
-4.68% |
|
-9.35% |
|
$0.82 |
|
$-0.16 |
|
$-0.16 |
|